Recent News

• 11.19.2025 - Avidity Biosciences Announces U.S. Managed Access Program (MAP) for Investigational Therapy del-zota in DMD44
• 11.10.2025 - Avidity Biosciences Reports Third Quarter 2025 Financial Results and Recent Highlights

Recent Filings

• 11.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 11.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 11.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 11.10.2025 - 8-K Current report
• 11.10.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 11.10.2025 - EX-99.1 EX-99.1
• 11.10.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.07.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 11.05.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 10.30.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors